James Vollins
Compliance Officer chez EIGER BIOPHARMACEUTICALS, INC.
Fortune : 12 160 $ au 30/04/2024
Postes actifs de James Vollins
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 13/04/2023 | - |
| Conseiller Juridique Général | 13/04/2023 | - | |
| Secrétaire Général | 13/04/2023 | - |
Historique de carrière de James Vollins
Anciens postes connus de James Vollins
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Compliance Officer | 05/11/2018 | 22/03/2022 |
| Conseiller Juridique Général | 05/11/2018 | 22/03/2022 | |
| Secrétaire Général | 05/11/2018 | 22/03/2022 | |
Bio Products Laboratory Ltd.
 Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Compliance Officer | 01/01/2014 | 01/10/2018 |
| Conseiller Juridique Général | 01/01/2014 | 01/10/2018 | |
| Secrétaire Général | 01/01/2014 | 01/10/2018 |
Formation de James Vollins
| Case Western Reserve University School of Law | Graduate Degree |
| Wesleyan University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
Opérationnelle
| Compliance Officer | 3 |
| General Counsel | 3 |
| Corporate Secretary | 3 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- James Vollins
- Expérience